Navigation Links
AMRI Announces Second Quarter 2014 Results
Date:8/5/2014

ALBANY, N.Y., Aug. 5, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2014.

Highlights:

  • Second quarter contract revenue of $61.5 million, up 21% from 2013
  • Second quarter adjusted diluted EPS of $0.22 vs. $0.11 in 2013
  • Expanded second quarter contract margins to 27% from 16% in 2013
  • Acquired Oso Biopharmaceuticals Manufacturing in July 2014, expanding contract manufacturing capabilities to include commercial scale, complex injectable drug product
  • Updated Financial Guidance 2014:

  • Full year contract revenue guidance increased to between $275 and $283 million, an increase of 33% at the midpoint
  • Royalty revenue guidance of $25 million
  • Adjusted EBITDA between $59 and $63 million, up 24% at the midpoint
  • Adjusted diluted EPS range between $0.87 and $0.92, compared to $0.70 in 2013, an increase of 28% at the midpoint, despite a $10 to $12 million decrease in estimated royalties from Allegra
  • Operating cash flow of $27 to $30 million
  • Adjusted diluted EPS and adjusted EBITDA are non-GAAP measures, which exclude certain items detailed later in this press release under the heading "Non-GAAP Adjustment Items."  Reconciliations of these non-GAAP measures to GAAP measures are included in Tables 1 and 2 at the end of this press release.

    "We are very pleased with our results this quarter, highlighted by a 34% growth in our large scale manufacturing business and the addition of Cedarburg Pharmaceuticals," said William S. Marth, AMRI's president and chief executive officer. "Importantly, contract margins improved across our entire operations as a result of increased capacity utilization and the addition of the higher margin Cedarburg Pharm
    '/>"/>

    SOURCE AMRI
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
    3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
    4. Misonix Announces New Distribution Agreement For Panama
    5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
    6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
    8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
    9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
    10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
    11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... and ATLANTA , August 28, ... US Food and Drug Administration (FDA) cleared the MagVita TMS ... adult patients who have failed to receive satisfactory improvement from ... non-invasive technique for stimulating neural tissue in the part of ... The procedure has been proven safe and effective and MagVenture ...
    (Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
    (Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
    Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5
    ... Asthma Medication Linked to Respiratory Improvement in NYC ... ... corticosteroids (ICS),antiinflammatory treatments often prescribed for asthma, may be beneficial,in preventing ... 2007, the 73rd annual international scientific assembly,of the American College of ...
    ... 24 Pharmasset, Inc.,(Nasdaq: VRUS ) has ... and,Drug Administration (FDA) for R7128 for the treatment ... a prodrug of PSI-6130, an oral cytidine,nucleoside analog ... Pharmasset,s collaboration with Roche. Pharmasset is currently,enrolling a ...
    Cached Medicine Technology:Inhaled Steriods Used as Preventive Treatment Post 9/11 2Inhaled Steriods Used as Preventive Treatment Post 9/11 3R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 2R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 3R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 4R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 5
    (Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
    (Date:8/28/2015)... CA (PRWEB) , ... August 28, 2015 , ... ... price on Zoom teeth whitening. For just $199, patients can currently receive a one ... traditional in-office teeth whitening procedures, but it includes a number of unique features that ...
    (Date:8/28/2015)... ... August 28, 2015 , ... The newest therapy to ... available for general use any time soon, according to educational website Surviving Mesothelioma. ... that received orphan drug designation for mesothelioma last week from the FDA, will now ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... now consolidated as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in ... number of custodial files the PSC may receive for corporate employees involved in ...
    (Date:8/28/2015)... ... 28, 2015 , ... An independent study recently conducted confirms ... of change to treatment recommendations and diagnosis. The 2015 return on investment (ROI) ... and analyzed WorldCare’s second opinion process. , The study reviewed cases across three ...
    Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:WorldCare International, Inc. Celebrates Findings of Independent ROI Study 2
    ... , ... poll, Supporting Iraq and Afghanistan Troops and Veterans, found two out of three Americans know ... and Afghanistan veterans and troops face. , ... Washington, DC (Vocus) May 10, 2010 -- A new public awareness poll, ...
    ... French . , Neurological research and clinical ... London and McGill University of Montreal entered an agreement ... field. Sir Keith O,Nions, Rector of Imperial, and Heather ... to sign the partnership documents, which will consolidate existing ...
    ... ... ... Clyburn will give the commencement address at the 135th Commencement ceremony for Meharry Medical College ... University in the Allen Arena. Doors open at 11:30 a.m., , , , ,Congressman Clyburn is ...
    ... show need for treatment even when pulmonary disease looks ... News) -- Worsening of chronic obstructive pulmonary disease (COPD) ... stroke, a new study finds. , British researchers looked ... in 426 patients and 633 ischemic strokes (blockage of ...
    ... help University of Central Florida researchers explore new ways ... and other neurological disorders. Stephen Lambert, an associate ... of UCF,s Hybrid Systems Laboratory, has received $428,000, the ... team will study the breakdown of myelin, a substance ...
    ... dyslexia often struggle with reading, writing, and spelling, despite ... other areas. New neurological research has found that these ... structural differences within an important information highway in the ... The findings are published in the June 2010 issue ...
    Cached Medicine News:Health News:New Poll Finds Majority of Americans Are Unaware of Issues Facing Iraq/Afghanistan Veterans and Troops 2Health News:New Poll Finds Majority of Americans Are Unaware of Issues Facing Iraq/Afghanistan Veterans and Troops 3Health News:Trans-Atlantic agreement a boost to neuroscience research 2Health News:Congressman James E. Clyburn to Give Meharry Medical College Commencement Address 2Health News:Congressman James E. Clyburn to Give Meharry Medical College Commencement Address 3Health News:$1.9 million grant to help UCF find multiple sclerosis 'nerve-ana' 2Health News:Differences in language circuits in the brain linked to dyslexia 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: